About us
Our Company
Welcome to follow this seedling. DLW Bioanalytics® was founded in 2025 in Sweden. We have a long history in obesity and diabetes from within the academic disciplines of endocrinology and gastroenterology. Over the past four decades, funding for biomedical and life sciences in academia has declined relative to growth in corresponding industries. For most researchers in academia, industry transformed from nicely dressed strangers we buy reagents from using government grants to our sole funders. Great ideas in academia needed industry level funding. Industry funding was accompanied by work pre-defined by industry they wanted performed by credible researchers. The solution was to migrate into industry and serve a niche needed by all: small and custom projects.
Many profound innovations happen at a small and custom scale. These are often user-driven by individuals or small groups with small budgets, but also small bureaucracies. Our funding mainly comes from small and custom projects with small and medium-sized enterprises (SMEs), the backbone of the Swedish economy. About 90% of you in Swedish life and medical sciences work at an SME; about 40% of Swedish SMEs are micro-sized (less than 10 employees). Sweden ranks high on the World Intellectual Property Organization (WIPO) Global Innovation Index, and this is driven by micro-sized SMEs. DLW Bioanalytics is well placed to serve this industry. Your SME gains access to a network of reliable and experienced professionals with education from top ranked universities with strong publishing and patenting experience. Welcome!
Our Goals
Serving your small and custom needs of course pays our bills. But it also builds our knowledge base we must continuously build upon for our own innovations that mainly happen on the small and custom scale. Our goal is therefore to build synergistic relationships. This is why we offer method development, quality control and validation. You need it, and so do we. DLW Bioanalytics® works directly with customers. No outsourcing. The person you meet is the person who performs the work.
Team

Abdul Halim, Clinical chemist - Chief medical liaison officer
Halim has been an important member of our team since 2011. He holds undergraduate degrees in biochemistry and molecular biology from Bangladesh. In Sweden, Halim holds a Master’s degree in biomedicine (Skövde University) and a PhD in medical sciences (Uppsala University). His PhD focused on methods for gut permeability assessment and mechanisms of GLP-1 and related drugs in human gut motility and the incretin effect. Halim is a licensed biomedical scientist. He spent 3 years at the clinical chemistry lab of Karolinska University Hospital (Solna) working with diagnostic instrumentation for ELISA, flow cytometry and thrombocyte aggregation. He also worked at Pathology Research Support and Diagnostic Laboratory, working with automated staining, workflows and quality-controlled diagnostic routines, progressing to area manager. Halim works at Unilabs (Pathology). He is experienced in digital pathology and image analysis (e.g., QuPath and ImageJ). He consults on health and safety representative (skyddsombud), working with environment regulations, risk assessment and laboratory workflow.
Academic CV & Publications at ORCiD
_____________________________________________

Daniel Hesse, Consulting business developer
First contact to first order is a scary monster for innovators starting businesses who are more familiar with writing research papers and patents. Someone, we propose Daniel, must reach out to procurement officers, QA/RA, CROs, distributors, KOLs, and end-users. Daniel is an expert at disentangling their conflicting incentives and scheduling, and transforming that into synergistic projects. He has decades of experience bridging sales, marketing and production in biotech/medtech. Daniel’s niche is opening sales channels, OEM deals as well as pricing, positioning and evidence plans. He has a team coaching approach. Daniel has worked with microsampling, analytical services, cell-media additives, automation and specialty reagents. By way of past employment at Abbott Diagnostics, Mercodia and TDB Labs, Daniel has many years of experience in the gastroenterology and endocrinology sectors.
_____________________________________________

Roger Högström, Consulting Chief Logistics Officer (CLO)
Small biotech and biomedical products startups are often founded by people like researchers from academia with little or no understanding of logistics. They are brilliant, innovative, motivated and they know their product. But they also discover that logistics is more massive and complex than accounting. The short list of people directly involved in a typical logistics supply chains are producers, buyers, manufacturers, warehousers (truck operators, managers), transport drivers, transport managers, purchasing officers and downstream customers. These all have to work together. Lead times must be managed; too many or too few of anything, or at wrong time, comes with costs. Roger Högström has decades of experience in small and medium businesses in the biotech, biomedical and pharmaceutical industry. Sometimes the problem to solve is sourcing boxes, bottles and labels. Other times, it is sorting out how to transport products to or from remote countries that most transport services don’t cover.
_____________________________________________

Dominic-Luc Webb, Founder
DLW Bioanalytics® is Dominic’s latest creation. It is also his latest experiment. He’s been
in his field since the 1980’s, mostly working in gastroenterology or endocrinology with
obesity and type 2 diabetes mellitus. He started his career in California, USA, having
studied at Merritt and Laney Colleges and University of California, Berkeley. He holds
a BS degree from Uppsala University and a PhD from Karolinska Institute. He did a
postdoc at University of California, Santa Cruz and was most recently associate professor
at Uppsala University from 2015-2025. Dominic ran a small business in California in the
1980’s and served as CEO for a micro-sized Swedish corporation in the 2000’s.
Academic CV & Publications at ORCiD
_____________________________________________
